- Home
- DGLY vs TOVX Comparison
DGLY vs TOVX Comparison
Compare DGLY & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- TOVX
- Stock Information
- Founded
- DGLY 2004
- TOVX 2001
- Country
- DGLY United States
- TOVX United States
- Employees
- DGLY N/A
- TOVX N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- TOVX Health Care
- Exchange
- DGLY Nasdaq
- TOVX Nasdaq
- Market Cap
- DGLY 3.2M
- TOVX 3.8M
- IPO Year
- DGLY N/A
- TOVX 2006
- Fundamental
- Price
- DGLY $1.82
- TOVX $0.33
- Analyst Decision
- DGLY
- TOVX Hold
- Analyst Count
- DGLY 0
- TOVX 1
- Target Price
- DGLY N/A
- TOVX N/A
- AVG Volume (30 Days)
- DGLY 26.0K
- TOVX 43.4M
- Earning Date
- DGLY 08-18-2025
- TOVX 11-11-2025
- Dividend Yield
- DGLY N/A
- TOVX N/A
- EPS Growth
- DGLY N/A
- TOVX N/A
- EPS
- DGLY N/A
- TOVX N/A
- Revenue
- DGLY $18,612,519.00
- TOVX N/A
- Revenue This Year
- DGLY N/A
- TOVX N/A
- Revenue Next Year
- DGLY $7.38
- TOVX N/A
- P/E Ratio
- DGLY N/A
- TOVX N/A
- Revenue Growth
- DGLY N/A
- TOVX N/A
- 52 Week Low
- DGLY $1.66
- TOVX $0.28
- 52 Week High
- DGLY $119.00
- TOVX $2.64
- Technical
- Relative Strength Index (RSI)
- DGLY 42.79
- TOVX 44.63
- Support Level
- DGLY $1.76
- TOVX $0.30
- Resistance Level
- DGLY $1.87
- TOVX $0.85
- Average True Range (ATR)
- DGLY 0.09
- TOVX 0.11
- MACD
- DGLY -0.02
- TOVX -0.02
- Stochastic Oscillator
- DGLY 15.00
- TOVX 8.32
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.